Interview with Graham Clarke

Abstract

Dr Graham Clarke is the senior director and head of the respiratory and inflammation unit, Early Clinical Development, at Quintiles, London. He leads the development and execution of inhaler generics and inhaler characterization studies, biomarker identification efforts and the development of challenge models of inflammation across several therapeutic areas. After previous appointments in molecular and forensic analytical biology and subsequently training as a clinical physiologist at the Royal Brompton Hospital, London, UK, Dr Clarke has served in a variety of respiratory clinical research environments. He is an honorary research fellow in cardiothoracic pharmacology at Imperial College London’s National Heart and Lung Institute. Dr Clarke completed a PhD in respiratory pharmacology and physiology with a focus on airway and vascular hyper-responsiveness in asthma at King’s College, London, UK.